跳至主要内容
临床试验/NCT04954807
NCT04954807已完成不适用

Growth and Body Composition of Low Birth Weight Infants Supplemented With Human Milk Fortifier After Discharge: A Double-Blind Randomized Clinical Trial

Indonesia University4 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2020年12月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
163
试验地点
4
主要终点
Gaining weight

研究概览

简要总结

Low birth weight (LBW) infant (1800-2449 gram) will be given the new human milk fortifier (HMF) which contains protein, lipid, carbohydrate and micronutrients after discharge. Human Milk Fortifier or placebo (carbohydrate only with similar calorie content) will be provided until 3 months of age. The investigators want to evaluate if the addition of HMF to mother's milk while breastfeeding LBW infants after discharge influences growth and body composition up to 3 months of age.

详细描述

This is a prospective two arms parallel double-blind randomized clinical trial in LBW infants. Clinically healthy LBW infants discharge on oral feeding of human milk before 2 weeks of age (< 15 days old) will be invited to participate in the study. Exclusively or predominantly breastfed infants will be encourage to use finger feeding as method of supplementation, but mothers can choose their own preferences if they wish to do so.

After signing the informed consent by parent, subject will be randomized to one of four group. Randomization list were prepare by one investigator who do not involve in recruitment, outcome measures and statistical analysis. Study product will be labeled as A, B, C D in similar tin. Only manufacturer know the content of these tins and the code will be revealed after statistical analysis completed. Parents will be given this 200 g tin of study product and ask to return the tin after 14 days of opening. Unblinded assistant will weight the tin before and after opening to estimate the HMF intake for 14 days.

This study will be conducted in several hospitals in Greater Jakarta.

Adherence to study protocol will be encouraged during face to face session initially in dispensing study product and subsequent visits (visit 1 at one-month-old, visit 2 at two months old). These sessions will include the reminder of the importance of following study protocol, breastfeeding support if needed and discussion about difficulties that arise. The investigators will also remind mothers via text to fill in three days diary of intake one week before each visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

One investigator who do not involve in recruitment and outcome measures will generate randomization list by computer application and set up the list into Redcap randomization set up. No one except him will know the sequence of randomization. Research assistant will randomize subjects into one of four group according to Redcap assignment. The manufacturer prepare the study product into four groups: A,B,C,D and kept the code until the statistical analysis completed. All investigators, care providers and study subjects aware of the active or placebo group. Research assistants who recruit the study subject are not allowed to open the tin. One research assistant who does no meet study subject will measure the weight of tin before and after the supplementation.

Subject only meet with researchers individually and will not meet other subjects so they will not know the content of the other tin.

入排标准

年龄范围
1 Day 至 14 Days(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Low birth weight infants (1800-2499 g) with oral feeding
  • •Exclusively breastfed or predominantly breastfed (consuming term infant formula less than 50 ml/Kg BW/day) at discharge
  • •Discharge from the hospital before 2 weeks of age and maximal age of enrolment is 14 days old
  • •Live in greater Jakarta
  • •Parents agree in writing to study participation and indicate their intention to follow study procedures.

排除标准

  • •Any subject who has major congenital anomaly or any other disorder(s) that infers with normal feeding, growth, and neurodevelopment.
  • •Participating in another intervention trial

研究组 & 干预措施

Human Milk Fortifier

Active Comparator

human milk fortifier which contains protein, lipid, carbohydrate and micronutrients

干预措施: human milk fortified (Dietary Supplement)

placebo

Placebo Comparator

Placebo is made of polysaccharides (0.9 g/1 g placebo) and maltose (0.1 g/1 g placebo) and minerals.

干预措施: placebo (Dietary Supplement)

结局指标

主要结局

Gaining weight

时间窗: three months of age

Gain in weight (g/kg initial weight \& difference) between study enrolment and three months of age

次要结局

  • Stool consistency(enrollment to three months of age)
  • Average weight gain(enrollment to three months of age)
  • Gaining length(Three months of age)
  • Head circumference(Three months of age)
  • Weight for age(Three months of age)
  • Body fat percentage(Three months of age)
  • Stool frequency(enrollment to three months of age)
  • Vomit(enrollment to three months of age)
  • Bloating(enrollment to three months of age)
  • Fever(enrollment to three months of age)
  • Rehospitalization(enrollment to three months of age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

yoga devaera

Head of Division of Nutrition and Metabolic Diseases of Child Health Dept

Indonesia University

研究点 (4)

Loading locations...

相似试验